As of 9:55 AM EDT, with the market open for trading, Pfizer Inc. (ticker: PFE) is navigating a session of tight trading. The stock is priced at 0.01 (+0.06%). For traders, this near-flat performance belies a more dynamic intraday story and presents a rich set of data points to analyze for potential opportunities.
This article breaks down every key metric from the trading screen to provide a comprehensive snapshot for traders evaluating Pfizer’s current standing.
I. Intraday Price Action and Performance
The intraday chart for Pfizer reveals a classic “gap down and recover” pattern in the early session.
-
Opening Price: The stock opened at 24.61. This indicates initial bearish sentiment at the market open.
-
Day’s Range: So far, the stock has traded between a low of 24.67. The current price of $24.63 is near the top of this range, suggesting a bullish recovery from the morning’s low.
-
Chart Analysis: The 1-day chart shows the price dipping after the open, finding a bottom around 9:00 AM, and then experiencing a sharp, vertical rally leading up to the current time. This V-shaped recovery is a significant event for day traders, indicating a strong influx of buying pressure that reversed the initial downward trend.
II. Key Trading Metrics: Liquidity and Order Book
Understanding the order book is critical for executing trades effectively.
-
Bid: $24.56 x 1600. This means there are active buyers willing to purchase 1,600 shares at a price of $24.56.
-
Ask: $24.57 x 2400. This means there are active sellers looking to sell 2,400 shares at a price of $24.57.
-
The Spread: The tight $0.01 spread between the bid and ask is a sign of high liquidity, which is typical for a large-cap stock like Pfizer. This means traders can enter and exit positions with minimal slippage.
III. Volume Analysis: Gauging Market Interest
Volume provides insight into the conviction behind price movements.
-
Current Volume: 8,142,127 shares. This is the number of shares traded so far in the session.
-
Average Volume: 42,621,821 shares. This is the average number of shares traded per day (typically over the last 3 months).
Analysis: Just 25 minutes into the main trading session, the volume is at approximately 19% of its full-day average. This level of activity is relatively standard for the first half-hour of trading. Traders should monitor whether the volume continues at this pace, accelerates, or dries up, as this will influence intraday volatility and trend strength.
IV. Valuation and Company Fundamentals
These metrics help traders understand Pfizer’s value in the broader market context.
-
Market Cap (Intraday): $139.889 Billion. This firmly places Pfizer in the “large-cap” category, indicating a stable, well-established company.
-
P/E Ratio (TTM): 17.83. The Price-to-Earnings ratio suggests that investors are willing to pay $17.83 for every $1 of Pfizer’s past year’s earnings. This is a moderate valuation that isn’t excessively high or low, often seen as reasonable in the pharmaceutical sector.
-
EPS (TTM): $1.38. This is the company’s Earnings Per Share over the Trailing Twelve Months. It’s the “E” in the P/E ratio and represents the core profitability on a per-share basis.
V. Risk and Historical Context
Assessing risk is paramount for any trading strategy.
-
Beta (5Y Monthly): 0.49. This is a critical risk metric. A beta below 1.0 indicates that the stock is historically less volatile than the overall market (as represented by the S&P 500). A beta of 0.49 suggests PFE moves, on average, about half as much as the market, making it a potentially defensive holding in a volatile market.
-
52-Week Range: $20.92 – $31.54. The current price of $24.63 is in the lower half of this range, significantly closer to the 52-week low than the high. Traders use this range to identify potential long-term support and resistance levels. The stock is well off its yearly highs, which could be interpreted as either a sign of weakness or a potential value opportunity.
VI. Future Outlook and Investor Incentives
These data points look ahead and can influence longer-term investment decisions.
-
Forward Dividend & Yield: $1.72 (7.10%). This is a very significant metric. Pfizer is projected to pay $1.72 per share in dividends over the next year, which translates to a high dividend yield of 7.10% at the current price. This is exceptionally attractive for income-focused investors and can provide a cushion during periods of market downturn.
-
Ex-Dividend Date: Jul 25, 2025. A trader or investor must own the stock before this date to be eligible to receive the next dividend payment.
-
Earnings Date: Aug 5, 2025. This is the next scheduled earnings report. Traders should mark this date, as earnings announcements are major catalysts for significant price volatility.
-
1y Target Est: $29.24. This is the consensus one-year price target from analysts covering the stock. This target suggests a potential upside of approximately 18.7% from the current price, indicating a generally bullish sentiment from the analyst community.
Summary for the Trader
Based purely on the data presented, a trader can form the following picture of Pfizer (PFE) at this moment:
-
Short-Term: The stock is showing intraday bullish momentum after reversing an early dip, but overall daily movement is minimal. Liquidity is high, allowing for easy trade execution.
-
Valuation: Pfizer appears moderately valued with a P/E ratio under 20.
-
Risk Profile: It is a low-volatility stock (Beta < 0.5), making it less risky than the broader market.
-
Investor Appeal: The primary appeal is its exceptionally high dividend yield (7.10%), which provides a strong income stream.
-
Potential: The stock is trading closer to its 52-week low than its high, while analyst targets suggest significant room for growth over the next year.
Traders can use this information to align PFE with their strategy, whether it be day trading based on the intraday reversal, swing trading based on the 52-week range, or a longer-term position to capture the high dividend yield and potential appreciation towards the analyst target.
Disclaimer: This article provides a detailed analysis of Pfizer (PFE) stock data as of a specific point in time. The information presented is for educational and informational purposes only and should not be construed as financial advice. Stock market data is highly volatile and changes rapidly. All trading and investment decisions should be made with the guidance of a qualified financial professional based on your individual financial situation and risk tolerance.
